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The association between the major histocompatibility antigen HLA-B27 and ankylosing spondylitis is the strongest of all known associations between class I HLA and disease. Over 90% of patients with ankylosing spondylitis have B27,1 whereas it is found only in 7-15% of normal white subjects. In addition, B27 is associated with certain reactive inflammatory conditions following gastrointestinal or urogenital infections. For example, about 80% of patients with reactive arthritis triggered by Yersinia enterocolitica or Yersinia pseudotuberculosis are B27 positive.2 Complete Reiter's syndrome, sacroiliitis, and acute anterior uveitis also belong to the same group of diseases.4 The collective term spondyloarthropathy is used for these diseases. It is commonly supposed that similar pathogenic mechanisms contribute to the development of all B27 associated diseases. An excess of B27 has also been described in psoriatic arthritis,5 in disorders of cardiac conduction,6 the latter reflecting the role of ankylosing spondylitis, in schizophrenia, 7 24 According to a controversial but theoretically satisfactory hypothesis the HLA-B27 molecule might act as a receptor for bacterial products. 25 Factors released from some klebsiella strains might bind to lymphocytes of B27 positive subjects, making them susceptible to lysis by klebsiella specific antisera. The problem with this theory is that the results have not been reproducible outside the original laboratory.
In addition to these theories, mainly concentrating on the structure of the B27 molecule, it has been suggested that the development of spondyloarthropathies is due to abnormal host defence mechanisms. This might be accomplished by B27 itself or by products of genes closely linked to the HLA-B locus. At present, genes for tumour necrosis factors, for a 70 kD heat shock protein, and for susceptibility to lysis by alloreactive natural killer cells are known as such genes. 2 28 In this article studies on the immune and inflammatory functions in HLA-B27 positive subjects are reviewed in the light of previously published work. We have tried to rule out the effects of the continuing disease process and the treatments given as far as possible.
Humoral immunity and B27
There is some evidence for an exceptionally strong antibody response, especially of the IgA class, in association with the B27 antigen. B27 positive healthy subjects have a higher proportion of the IgAl subclass of their serum IgA than B27 negative controls, and their unstimulated lymphocytes showed decreased IgM production. 29 Higher antibody titres to streptokinase/ streptodornase have been shown in B27 positive subjects with ankylosing spondylitis and in B27 positive healthy controls than in B27 negative controls. 31 The number and percentage of B lymphocytes are similar in B27 positive and negative subjects, and no difference has been observed in anti-candida, anti-E coli, antistreptolysin titres, or in titres of antinuclear, parietal cell, and smooth muscle autoantibodies.3' It is well documented that patients with yersinia triggered reactive arthritis have a stronger and more persisting IgA class antibody response to the causative micro-organism than 32 33 patients with uncomplicated yersiniosis. In addition to enhanced polymorphonuclear leucocyte activity, humoral inflammatory mechanisms may also be exaggerated in B27 positive subjects. Increased production of tumour necrosis factors and interleukin-1 has been reported.50 Furthermore, increased production of the anaphylatoxin C3a and C3d,g in vitro as stimulated by lipopolysaccharide has been noted in B27 positive subjects, while the concentrations of complement factors are normal.5' Interestingly, low concentrations of complement C3b receptors (CR1) on erythrocytes have been associated with HLA-B27 in normal subjects52 and in yersinia triggered reactive arthritis.53 Similarly, lack of C3b receptors on erythrocytes has been associated with B27 positivity in patients with juvenile rheumatoid arthritis.54 It is possible that this kind of deficiency might cause ineffective elimination of foreign antigens and, if accompanied by exaggerated inflammatory mechanisms, further contribute to the pathogenesis of B27 associated diseases.
In their recent studies Repo et al re-evaluated some of their findings indicating increased polymorphonuclear leucocyte functions in association with B27 antigen. They noted that serum samples of B27 positive children have normal ability to enhance neutrophil migration.55 They concluded that the difference between B27 positive and negative subjects may be acquired secondarily and is not genetically determined. In further studies Pease et al also suggest, in contrast with their previous work,45 that healthy B27 positive subjects and B27 positive relatives of patients with ankylosing spondylitis have normal neutrophil motility and that the previously noted differences might be due to the disease itself or to the drugs used.56
Concluding remarks Obviously no defmite differences in the immune and inflammatory functions of B27 positive and negative subjects are apparent as each observation is matched by a contradictory report. Nevertheless, it is tempting to mention some tendencies noted to be associated with B27: (a) antibody levels to some antigens may be increased, especially in the IgA class; (b) cell mediated immunity may be diminished in some in vitro systems; (c) some functions of cellular and humoral inflammatory reaction may be increased, and elimination ofcirculating antigens by certain immune functions may be impaired.
None of the tendencies is prominent enough to explain the disease associations of B27, but one functional aspect has so far been almost completely neglected-the cellular processing and presentation of antigens.
Class I HLA molecules present on the cell surface 'endogenous' antigens-that is, antigens synthesised within the antigen presenting cell57; the cells responding to the antigen presentation are usually cytostatic CD8 positive T cells. If this pathway could be shown to be aberrant in B27 positive subjects it would be a key to understanding thepathogenesisofB27 associated diseases. So far, no available evidence points in this interesting direction.
For the structural features of the B27 molecule to be decisive they should be those in the common determinants of the molecule because all three major subtypes of B27 are equally associated with disease. 
